These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 36753245)

  • 1. [The "Carmen de Bolívar event" in HPV vaccination in Colombia. Cause or outcome?].
    Henríquez-Mendoza GM
    Rev Salud Publica (Bogota); 2020 Jul; 22(4):447-452. PubMed ID: 36753245
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mass psychogenic illness following HPV immunization in Carmen de Bolivar, Colombia (2014): more uncertainty is required.
    Idrovo AJ; Pinilla-Monsalve GD; Manrique-Hernández EF
    Hum Vaccin Immunother; 2019; 15(5):1199-1200. PubMed ID: 30735450
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HPV vaccine confidence and cases of mass psychogenic illness following immunization in Carmen de Bolivar, Colombia.
    Simas C; Munoz N; Arregoces L; Larson HJ
    Hum Vaccin Immunother; 2019; 15(1):163-166. PubMed ID: 30118381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Social considerations affecting acceptance of HPV vaccination in Colombia. A systematic review].
    Palencia-Sánchez F; Echeverry-Coral SJ
    Rev Colomb Obstet Ginecol; 2020 Jun; 71(2):178-194. PubMed ID: 32770873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk perception and sexual behavior in HPV-vaccinated and unvaccinated young Colombian women.
    Ruiz-Sternberg AM; Pinzón-Rondón ÁM
    Int J Gynaecol Obstet; 2014 Sep; 126(3):205-8. PubMed ID: 24996685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reply letter re: "Mass psychogenic illness following HPV immunization in Carmen de Bolivar, Colombia".
    Simas C; Munoz N; Arregoces L; Larson HJ
    Hum Vaccin Immunother; 2019; 15(5):1201-1202. PubMed ID: 30946630
    [No Abstract]   [Full Text] [Related]  

  • 7. Reduction in Vaccine HPV Type Infections in a Young Women Group (18-25 Years) Five Years after HPV Vaccine Introduction in Colombia.
    Combita AL; Reyes V; Puerto D; Murillo R; Sánchez R; Nuñez M; Hernandez-Suarez GA; Wiesner C
    Cancer Prev Res (Phila); 2022 Jan; 15(1):55-66. PubMed ID: 34610993
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tanzania's human papillomavirus (HPV) vaccination program: Community awareness, feasibility, and acceptability of a national HPV vaccination program, 2019.
    Li AJ; Manzi F; Kyesi F; Makame Y; Mwengee W; Fleming M; Mkopi A; Mmbaga S; Lyimo D; Loharikar A
    Vaccine; 2022 Mar; 40 Suppl 1(Suppl 1):A38-A48. PubMed ID: 34229889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of Parent's awareness, knowledge, perception, and acceptability of human papillomavirus vaccination after a structured-educational intervention.
    Sitaresmi MN; Rozanti NM; Simangunsong LB; Wahab A
    BMC Public Health; 2020 Dec; 20(1):1836. PubMed ID: 33256697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Understanding human papillomavirus vaccination intentions: comparative utility of the theory of reasoned action and the theory of planned behavior in vaccine target age women and men.
    Fisher WA; Kohut T; Salisbury CM; Salvadori MI
    J Sex Med; 2013 Oct; 10(10):2455-64. PubMed ID: 23745833
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perception about barriers and facilitators of the school-based HPV vaccine program of Manizales, Colombia: A qualitative study in school-enrolled girls and their parents.
    Cordoba-Sanchez V; Tovar-Aguirre OL; Franco S; Arias Ortiz NE; Louie K; Sanchez GI; Garces-Palacio IC
    Prev Med Rep; 2019 Dec; 16():100977. PubMed ID: 31508297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of having heard about human papillomavirus vaccination: Critical aspects for cervical cancer prevention among Colombian women.
    Bermedo-Carrasco S; Feng CX; Peña-Sánchez JN; Lepnurm R
    Gac Sanit; 2015; 29(2):112-7. PubMed ID: 25444387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intent to receive HPV vaccine and reasons for not vaccinating among unvaccinated adolescent and young women: findings from the 2006-2008 National Survey of Family Growth.
    Liddon NC; Hood JE; Leichliter JS
    Vaccine; 2012 Mar; 30(16):2676-82. PubMed ID: 22342548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Perceptions of Human Papillomavirus (HPV) infection and acceptability of HPV vaccine among men attending a sexual health clinic differ according to sexual orientation.
    Giuliani M; Vescio MF; Donà MG; Latini A; Frasca M; Colafigli M; Farinella M; Rezza G; Cristaudo A
    Hum Vaccin Immunother; 2016 Jun; 12(6):1542-50. PubMed ID: 26752151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acceptability of using standing orders to deliver human papillomavirus vaccines in the outpatient obstetrician/gynecologist setting.
    Dempsey AF; Pyrzanowski J; Brewer S; Barnard J; Sevick C; O'Leary ST
    Vaccine; 2015 Apr; 33(15):1773-9. PubMed ID: 25731788
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Men who have sex with men who do not access sexual health clinics nor disclose sexual orientation are unlikely to receive the HPV vaccine in the UK.
    Nadarzynski T; Smith H; Richardson D; Bremner S; Llewellyn C
    Vaccine; 2018 Aug; 36(33):5065-5070. PubMed ID: 30037419
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An exploratory study of Japanese fathers' knowledge of and attitudes towards HPV and HPV vaccination: does marital status matter?
    Hanley SJ; Yoshioka E; Ito Y; Konno R; Sasaki Y; Kishi R; Sakuragi N
    Asian Pac J Cancer Prev; 2014; 15(4):1837-43. PubMed ID: 24641418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knowledge and willingness of parents towards child girl HPV vaccination in Debre Tabor Town, Ethiopia: a community-based cross-sectional study.
    Mihretie GN; Liyeh TM; Ayele AD; Belay HG; Yimer TS; Miskr AD
    Reprod Health; 2022 Jun; 19(1):136. PubMed ID: 35689288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning suffering into side effects: Responses to HPV vaccination in Colombia.
    Mezza M; Blume S
    Soc Sci Med; 2021 Aug; 282():114135. PubMed ID: 34146986
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acceptability of vaccination against human papillomavirus among women aged 20 to 45 in rural Hunan Province, China: A cross-sectional study.
    Qin S; Fu JX; Chen MZ; Meng YT; Xu C; Luo Y
    Vaccine; 2020 Jun; 38(30):4732-4739. PubMed ID: 32471777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.